Aim: Percutaneous renal biopsy (PRB) remains the gold standard for the diagnosis of renal disease; however, the tissue yield which relates to the optimal needle size used for native-kidney biopsies has not been clearly established. Our study compares the sample adequacy and complication rates using 16 gauge (G) and 18 gauge (G) automatic needles on native kidney PRB.
Methods: A retrospective analysis was performed of native-kidney biopsies at two centres, one exclusively using 16G and the other exclusively using 18G needles. All samples were assessed by a single centralized pathology service. We compared patient characteristics, indications, diagnoses, adequacy of tissue samples, and complications.
Results: A total of 934 native-kidney biopsies were performed with real time ultrasound guidance: 753 with Bard Max Core 16G × 16 cm needles, and 181 with Bard Magnum 18G × 20 cm needles. The median (range) of total glomeruli count per biopsy was higher in the 16G group compared with the 18G group (19 (0-66) vs. 12 (0-35), P < 0.001), despite having fewer cores per biopsy (2 (0-4) vs. 3 (1-4), P < 0.001). The 16G group provided a greater proportion of adequate biopsy samples (94.7% vs. 89.4%, P = 0.001). There was no significant difference in the frequency of total complications between the 16G and 18G groups (3.7% vs. 2.2%, P = 0.49).
Conclusion: This retrospective study demonstrates 16G needles provide more glomeruli, more diagnostically adequate renal tissue, with fewer cores without a significant increase in complications compared with 18G needles. Based on these observations, 16G needles should be considered as the first line option in native-kidney PRB.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/nep.12093 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Monoclonal gammopathy is present in one fourth of patients undergoing renal biopsy but is pathogenic only in half of them.
J Nephrol
December 2024
Nephrology, Dialysis and Transplantation Unit, Careggi University Hospital, Largo Brambilla, 3, 50134, Florence, Italy.
Background: About 4-7% of renal biopsies show a monoclonal gammopathy-related nephropathy, such as AL amyloidosis, cast nephropathy, or light chain deposition disease. Both a high prevalence and a causal role of monoclonal gammopathy have been observed in patients with C3 glomerulopathy or thrombotic microangiopathy, although a definitive causative role cannot be established in most cases (potentially monoclonal gammopathy-related nephropathies). A coexisting monoclonal gammopathy has been identified in many cases of nephropathy without a defined causative role (monoclonal gammopathy-unrelated nephropathies).
View Article and Find Full Text PDFCharacteristics of glomerulonephritis with dominant C1q precipitation compared to corresponding glomerulonephritis without C1q staining on immunofluorescent examination.
Kidney Res Clin Pract
November 2024
Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Republic of Korea.
Background: The clinical significance and renal outcomes of C1q nephropathy (C1qN) are unclear; therefore, the implications of C1qN as a new pathological entity are uncertain. We compared the clinical characteristics of glomerulonephritis reclassified into cases that meet the definition of C1qN and glomerulonephritis not included in the definition of C1qN.
Methods: In total, 21,697 patients who underwent native kidney biopsy at 18 hospitals throughout Korea between 1979 and 2018 were retrospectively enrolled.
Clinicopathological characteristics of patients with low titer anti-phospholipase A2 receptor antibodies verified by indirect immunofluorescence assay.
Clin Chim Acta
December 2024
Nephrology Division, Peking Union Medical College Hospital, No 1, Shuaifuyuan, Wangfujing St, Beijing 100730, PR China.
Article Synopsis
- This study investigates the diagnostic accuracy of indirect immunofluorescence (IIF) for assessing anti-phospholipase A2 receptor antibodies (PLA2R-abs) in patients with inconclusive grey-zone results from enzyme-linked immunosorbent assay (ELISA) related to primary membranous nephropathy (pMN).
- Among 52 patients with grey-zone results, those diagnosed with pMN had significantly higher levels of PLA2R-abs and lower serum creatinine than those with non-pMN conditions.
- The PLA2R-IIF showed a sensitivity of 72% and specificity of 88%, indicating it could enhance diagnostic confidence in grey-zone patients.
Late Recurrence of C3 Glomerulopathy After SARS-CoV-2 Infection in a Long-Term Kidney Transplant Recipient: A Case Report.
Am J Case Rep
December 2024
Department of Translational Medicine and Surgery, Università Cattolica del Sacro Cuore, Roma, Italy.
Article Synopsis
- Kidney transplantation is the best treatment for end-stage kidney disease, but long-term success can be affected by issues like recurrence of native kidney diseases such as C3 glomerulopathy (C3GN).
- A case study documented a female kidney transplant recipient whose kidney function declined after 28 years due to two SARS-CoV-2 infections, alongside evidence of chronic rejection and features of C3GN in her recent biopsy.
- The findings suggest that C3GN may have recurred late in this patient as a result of complement activation triggered by the SARS-CoV-2 infections, indicating a potential new risk factor for post-transplant complications.
Image-guided renal parenchymal biopsies- how we do it.
Abdom Radiol (NY)
November 2024
Brigham and Women's Hospital, Harvard Medical School, Boston, USA.
This paper is a multi-institutional review of image-guided renal parenchymal biopsies. Among the topics covered are indications, preprocedural considerations, biopsy technique, complications, and postprocedural management. Both native kidney and transplant kidney biopsies are considered in this review.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!